Goldriver, California

  • MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms

    This study is a multicenter, parallel-group, controlled, double-masked (subject and investigator), randomized clinical trial with a total duration of four years. Part 1 of this study will study the effectiveness of MiSight 1 Day in slowing myopia progression over three years in a US population. Subjects in Part 1 will wear MiSight 1 Day lenses or Proclear 1 day lenses. Part 2 will study the stability of the effectiveness result over a one-year post-treatment period. All subjects in Part 2 will wear Proclear 1 day lenses. Subjects and investigators will remain masked from Part 1.

    Phase

    N/A

    Span

    262 weeks

    Sponsor

    Coopervision, Inc.

    Palatine, Illinois

    Recruiting

    Healthy Volunteers

1-1 of 1